National Health (Pharmaceutical Benefits – early supply) Amendment Instrument 2019 (No. 6) (PB 47 of 2019) (Cth)
PB 47 of 2019
National Health (Pharmaceutical Benefits – early supply) Amendment Instrument 2019 (No. 6)
National Health Act 1953
___________________________________________________________________________
I, THEA DANIEL, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.
Dated 27 June 2019
THEA DANIEL
Assistant Secretary
Pricing and PBS Policy Branch
Technology Assessment and Access Division
Department of Health
___________________________________________________________________________
Name of Instrument
(1)This Instrument is the National Health (Pharmaceutical Benefits – early supply) Amendment Instrument 2019 (No. 6).
(2)This Instrument may also be cited as PB 47 of 2019.
Commencement
This Instrument commences on 1 July 2019.
Amendment of National Health (Pharmaceutical Benefits—early supply) Instrument 2015 (PB 120 of 2015)
Schedule 1 amends the National Health (Pharmaceutical Benefits—early supply) Instrument 2015 (PB 120 of 2015).
Schedule 1 Amendments
Schedule 1, entry for Esomeprazole
substitute:
| Esomeprazole | Capsule (enteric) 20 mg (as magnesium) | 20 | 30 | 5 |
| Capsule (enteric) 40 mg (as magnesium) | 20 | 30 | 5 | |
| Tablet (enteric coated) 20 mg (as magnesium trihydrate) | 20 | 30 | 5 | |
| Tablet (enteric coated) 40 mg (as magnesium trihydrate) | 20 | 30 | 5 |
Schedule 1, omit entry for Glatiramer
Schedule 1, omit entry for Isotretinoin
Schedule 1, entry for Lansoprazole
substitute:
| Lansoprazole | Capsule 15 mg | 20 | 30 | 5 |
| Capsule 30 mg | 20 | 28 | 5 | |
| Tablet 15 mg (orally disintegrating) | 20 | 28 | 5 | |
| Tablet 30 mg (orally disintegrating) | 20 | 28 | 5 |
Schedule 1, entry for Omeprazole
substitute:
| Omeprazole | Capsule 20 mg | 20 | 30 | 5 |
| Tablet 10 mg (as magnesium) | 20 | 30 | 5 | |
| Tablet 20 mg | 20 | 30 | 5 | |
| Tablet 20 mg (as magnesium) | 20 | 30 | 5 |
Schedule 1, entry for Pantoprazole
substitute:
| Pantoprazole | Sachet containing granules 40 mg (as sodium sesquihydrate) | 20 | 30 | 5 |
| Tablet (enteric coated) 20 mg (as sodium sesquihydrate) | 20 | 30 | 5 | |
| Tablet (enteric coated) 40 mg (as sodium sesquihydrate) | 20 | 30 | 5 |
Schedule 1, entry for Rabeprazole
substitute:
| Rabeprazole | Tablet containing rabeprazole sodium 10 mg (enteric coated) | 20 | 28 | 5 |
| Tablet containing rabeprazole sodium 20 mg (enteric coated) | 20 | 30 | 5 |
Schedule 1, omit entry for Rosiglitazone with metformin
0
0
0